▶ 調査レポート

世界の海洋バイオベースオメガ3市場(~2028年):DHA、EPA

• 英文タイトル:Global Marine Bio-Based Omega 3 Market Insights, Forecast to 2028

Global Marine Bio-Based Omega 3 Market Insights, Forecast to 2028「世界の海洋バイオベースオメガ3市場(~2028年):DHA、EPA」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2Q12-02434
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、118ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、海洋バイオベースオメガ3のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
海洋バイオベースオメガ3のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
海洋バイオベースオメガ3の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
海洋バイオベースオメガ3のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までの海洋バイオベースオメガ3の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の海洋バイオベースオメガ3の売上および2028年までの予測に焦点を当てています。

海洋バイオベースオメガ3のグローバル主要企業には、DSM、BASF、Pelagia (EPAX)、Golden Omega、TASA、Omega Protein、Croda、GC Rieber、Polaris、Yuwang、Auqi、Kinomega、Skuny、Xinzhou、Renpu Pharmaceuticals、Sinomegaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

海洋バイオベースオメガ3市場は、タイプとアプリケーションによって区分されます。世界の海洋バイオベースオメガ3市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
DHA、EPA

【アプリケーション別セグメント】
栄養補助食品、栄養強化食品・飲料、粉ミルク、医薬品、ペットフード、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 海洋バイオベースオメガ3製品概要
- タイプ別市場(DHA、EPA)
- アプリケーション別市場(栄養補助食品、栄養強化食品・飲料、粉ミルク、医薬品、ペットフード、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の海洋バイオベースオメガ3販売量予測2017-2028
- 世界の海洋バイオベースオメガ3売上予測2017-2028
- 海洋バイオベースオメガ3の地域別販売量
- 海洋バイオベースオメガ3の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別海洋バイオベースオメガ3販売量
- 主要メーカー別海洋バイオベースオメガ3売上
- 主要メーカー別海洋バイオベースオメガ3価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模(DHA、EPA)
- 海洋バイオベースオメガ3のタイプ別販売量
- 海洋バイオベースオメガ3のタイプ別売上
- 海洋バイオベースオメガ3のタイプ別価格
・アプリケーション別市場規模(栄養補助食品、栄養強化食品・飲料、粉ミルク、医薬品、ペットフード、その他)
- 海洋バイオベースオメガ3のアプリケーション別販売量
- 海洋バイオベースオメガ3のアプリケーション別売上
- 海洋バイオベースオメガ3のアプリケーション別価格
・北米市場
- 北米の海洋バイオベースオメガ3市場規模(タイプ別、アプリケーション別)
- 主要国別の海洋バイオベースオメガ3市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの海洋バイオベースオメガ3市場規模(タイプ別、アプリケーション別)
- 主要国別の海洋バイオベースオメガ3市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の海洋バイオベースオメガ3市場規模(タイプ別、アプリケーション別)
- 主要国別の海洋バイオベースオメガ3市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の海洋バイオベースオメガ3市場規模(タイプ別、アプリケーション別)
- 主要国別の海洋バイオベースオメガ3市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの海洋バイオベースオメガ3市場規模(タイプ別、アプリケーション別)
- 主要国別の海洋バイオベースオメガ3市場規模(トルコ、サウジアラビア)
・企業情報
DSM、BASF、Pelagia (EPAX)、Golden Omega、TASA、Omega Protein、Croda、GC Rieber、Polaris、Yuwang、Auqi、Kinomega、Skuny、Xinzhou、Renpu Pharmaceuticals、Sinomega
・産業チェーン及び販売チャネル分析
- 海洋バイオベースオメガ3の産業チェーン分析
- 海洋バイオベースオメガ3の原材料
- 海洋バイオベースオメガ3の生産プロセス
- 海洋バイオベースオメガ3の販売及びマーケティング
- 海洋バイオベースオメガ3の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 海洋バイオベースオメガ3の産業動向
- 海洋バイオベースオメガ3のマーケットドライバー
- 海洋バイオベースオメガ3の課題
- 海洋バイオベースオメガ3の阻害要因
・主な調査結果

Fish oil is a natural source of omega-3 long-chain polyunsaturated fatty acids (EPA and DHA), which are essential nutrients for all vertebrates
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Marine Bio-Based Omega 3 estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Marine Bio-Based Omega 3 is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Marine Bio-Based Omega 3 is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Marine Bio-Based Omega 3 is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Marine Bio-Based Omega 3 include DSM, BASF, Pelagia (EPAX), Golden Omega, TASA, Omega Protein, Croda, GC Rieber and Polaris, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Marine Bio-Based Omega 3 production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Marine Bio-Based Omega 3 by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Marine Bio-Based Omega 3 manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Marine Bio-Based Omega 3 market. Further, it explains the major drivers and regional dynamics of the global Marine Bio-Based Omega 3 market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
DSM
BASF
Pelagia (EPAX)
Golden Omega
TASA
Omega Protein
Croda
GC Rieber
Polaris
Yuwang
Auqi
Kinomega
Skuny
Xinzhou
Renpu Pharmaceuticals
Sinomega
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Marine Bio-Based Omega 3 Segment by Type
DHA
EPA
Marine Bio-Based Omega 3 Segment by Application
Dietary Supplements
Fortified Foods and Beverages
Infant Formula
Drug
Pet Food
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Marine Bio-Based Omega 3 production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Marine Bio-Based Omega 3 market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Marine Bio-Based Omega 3, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Marine Bio-Based Omega 3, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Marine Bio-Based Omega 3, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Marine Bio-Based Omega 3 sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Marine Bio-Based Omega 3 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Marine Bio-Based Omega 3 sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including DSM, BASF, Pelagia (EPAX), Golden Omega, TASA, Omega Protein, Croda, GC Rieber and Polaris, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Marine Bio-Based Omega 3 capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Marine Bio-Based Omega 3 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Marine Bio-Based Omega 3 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Marine Bio-Based Omega 3 sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Marine Bio-Based Omega 3 Product Introduction
1.2 Market by Type
1.2.1 Global Marine Bio-Based Omega 3 Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 DHA
1.2.3 EPA
1.3 Market by Application
1.3.1 Global Marine Bio-Based Omega 3 Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Dietary Supplements
1.3.3 Fortified Foods and Beverages
1.3.4 Infant Formula
1.3.5 Drug
1.3.6 Pet Food
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Marine Bio-Based Omega 3 Production
2.1 Global Marine Bio-Based Omega 3 Production Capacity (2017-2028)
2.2 Global Marine Bio-Based Omega 3 Production by Region: 2017 VS 2021 VS 2028
2.3 Global Marine Bio-Based Omega 3 Production by Region
2.3.1 Global Marine Bio-Based Omega 3 Historic Production by Region (2017-2022)
2.3.2 Global Marine Bio-Based Omega 3 Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Marine Bio-Based Omega 3 Sales in Volume & Value Estimates and Forecasts
3.1 Global Marine Bio-Based Omega 3 Sales Estimates and Forecasts 2017-2028
3.2 Global Marine Bio-Based Omega 3 Revenue Estimates and Forecasts 2017-2028
3.3 Global Marine Bio-Based Omega 3 Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Marine Bio-Based Omega 3 Sales by Region
3.4.1 Global Marine Bio-Based Omega 3 Sales by Region (2017-2022)
3.4.2 Global Sales Marine Bio-Based Omega 3 by Region (2023-2028)
3.5 Global Marine Bio-Based Omega 3 Revenue by Region
3.5.1 Global Marine Bio-Based Omega 3 Revenue by Region (2017-2022)
3.5.2 Global Marine Bio-Based Omega 3 Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Marine Bio-Based Omega 3 Production Capacity by Manufacturers
4.2 Global Marine Bio-Based Omega 3 Sales by Manufacturers
4.2.1 Global Marine Bio-Based Omega 3 Sales by Manufacturers (2017-2022)
4.2.2 Global Marine Bio-Based Omega 3 Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Marine Bio-Based Omega 3 in 2021
4.3 Global Marine Bio-Based Omega 3 Revenue by Manufacturers
4.3.1 Global Marine Bio-Based Omega 3 Revenue by Manufacturers (2017-2022)
4.3.2 Global Marine Bio-Based Omega 3 Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Marine Bio-Based Omega 3 Revenue in 2021
4.4 Global Marine Bio-Based Omega 3 Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Marine Bio-Based Omega 3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Marine Bio-Based Omega 3 Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Marine Bio-Based Omega 3 Sales by Type
5.1.1 Global Marine Bio-Based Omega 3 Historical Sales by Type (2017-2022)
5.1.2 Global Marine Bio-Based Omega 3 Forecasted Sales by Type (2023-2028)
5.1.3 Global Marine Bio-Based Omega 3 Sales Market Share by Type (2017-2028)
5.2 Global Marine Bio-Based Omega 3 Revenue by Type
5.2.1 Global Marine Bio-Based Omega 3 Historical Revenue by Type (2017-2022)
5.2.2 Global Marine Bio-Based Omega 3 Forecasted Revenue by Type (2023-2028)
5.2.3 Global Marine Bio-Based Omega 3 Revenue Market Share by Type (2017-2028)
5.3 Global Marine Bio-Based Omega 3 Price by Type
5.3.1 Global Marine Bio-Based Omega 3 Price by Type (2017-2022)
5.3.2 Global Marine Bio-Based Omega 3 Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Marine Bio-Based Omega 3 Sales by Application
6.1.1 Global Marine Bio-Based Omega 3 Historical Sales by Application (2017-2022)
6.1.2 Global Marine Bio-Based Omega 3 Forecasted Sales by Application (2023-2028)
6.1.3 Global Marine Bio-Based Omega 3 Sales Market Share by Application (2017-2028)
6.2 Global Marine Bio-Based Omega 3 Revenue by Application
6.2.1 Global Marine Bio-Based Omega 3 Historical Revenue by Application (2017-2022)
6.2.2 Global Marine Bio-Based Omega 3 Forecasted Revenue by Application (2023-2028)
6.2.3 Global Marine Bio-Based Omega 3 Revenue Market Share by Application (2017-2028)
6.3 Global Marine Bio-Based Omega 3 Price by Application
6.3.1 Global Marine Bio-Based Omega 3 Price by Application (2017-2022)
6.3.2 Global Marine Bio-Based Omega 3 Price Forecast by Application (2023-2028)
7 North America
7.1 North America Marine Bio-Based Omega 3 Market Size by Type
7.1.1 North America Marine Bio-Based Omega 3 Sales by Type (2017-2028)
7.1.2 North America Marine Bio-Based Omega 3 Revenue by Type (2017-2028)
7.2 North America Marine Bio-Based Omega 3 Market Size by Application
7.2.1 North America Marine Bio-Based Omega 3 Sales by Application (2017-2028)
7.2.2 North America Marine Bio-Based Omega 3 Revenue by Application (2017-2028)
7.3 North America Marine Bio-Based Omega 3 Sales by Country
7.3.1 North America Marine Bio-Based Omega 3 Sales by Country (2017-2028)
7.3.2 North America Marine Bio-Based Omega 3 Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Marine Bio-Based Omega 3 Market Size by Type
8.1.1 Europe Marine Bio-Based Omega 3 Sales by Type (2017-2028)
8.1.2 Europe Marine Bio-Based Omega 3 Revenue by Type (2017-2028)
8.2 Europe Marine Bio-Based Omega 3 Market Size by Application
8.2.1 Europe Marine Bio-Based Omega 3 Sales by Application (2017-2028)
8.2.2 Europe Marine Bio-Based Omega 3 Revenue by Application (2017-2028)
8.3 Europe Marine Bio-Based Omega 3 Sales by Country
8.3.1 Europe Marine Bio-Based Omega 3 Sales by Country (2017-2028)
8.3.2 Europe Marine Bio-Based Omega 3 Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Marine Bio-Based Omega 3 Market Size by Type
9.1.1 Asia Pacific Marine Bio-Based Omega 3 Sales by Type (2017-2028)
9.1.2 Asia Pacific Marine Bio-Based Omega 3 Revenue by Type (2017-2028)
9.2 Asia Pacific Marine Bio-Based Omega 3 Market Size by Application
9.2.1 Asia Pacific Marine Bio-Based Omega 3 Sales by Application (2017-2028)
9.2.2 Asia Pacific Marine Bio-Based Omega 3 Revenue by Application (2017-2028)
9.3 Asia Pacific Marine Bio-Based Omega 3 Sales by Region
9.3.1 Asia Pacific Marine Bio-Based Omega 3 Sales by Region (2017-2028)
9.3.2 Asia Pacific Marine Bio-Based Omega 3 Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Marine Bio-Based Omega 3 Market Size by Type
10.1.1 Latin America Marine Bio-Based Omega 3 Sales by Type (2017-2028)
10.1.2 Latin America Marine Bio-Based Omega 3 Revenue by Type (2017-2028)
10.2 Latin America Marine Bio-Based Omega 3 Market Size by Application
10.2.1 Latin America Marine Bio-Based Omega 3 Sales by Application (2017-2028)
10.2.2 Latin America Marine Bio-Based Omega 3 Revenue by Application (2017-2028)
10.3 Latin America Marine Bio-Based Omega 3 Sales by Country
10.3.1 Latin America Marine Bio-Based Omega 3 Sales by Country (2017-2028)
10.3.2 Latin America Marine Bio-Based Omega 3 Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Marine Bio-Based Omega 3 Market Size by Type
11.1.1 Middle East and Africa Marine Bio-Based Omega 3 Sales by Type (2017-2028)
11.1.2 Middle East and Africa Marine Bio-Based Omega 3 Revenue by Type (2017-2028)
11.2 Middle East and Africa Marine Bio-Based Omega 3 Market Size by Application
11.2.1 Middle East and Africa Marine Bio-Based Omega 3 Sales by Application (2017-2028)
11.2.2 Middle East and Africa Marine Bio-Based Omega 3 Revenue by Application (2017-2028)
11.3 Middle East and Africa Marine Bio-Based Omega 3 Sales by Country
11.3.1 Middle East and Africa Marine Bio-Based Omega 3 Sales by Country (2017-2028)
11.3.2 Middle East and Africa Marine Bio-Based Omega 3 Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 DSM
12.1.1 DSM Corporation Information
12.1.2 DSM Overview
12.1.3 DSM Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 DSM Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 DSM Recent Developments
12.2 BASF
12.2.1 BASF Corporation Information
12.2.2 BASF Overview
12.2.3 BASF Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 BASF Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 BASF Recent Developments
12.3 Pelagia (EPAX)
12.3.1 Pelagia (EPAX) Corporation Information
12.3.2 Pelagia (EPAX) Overview
12.3.3 Pelagia (EPAX) Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Pelagia (EPAX) Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Pelagia (EPAX) Recent Developments
12.4 Golden Omega
12.4.1 Golden Omega Corporation Information
12.4.2 Golden Omega Overview
12.4.3 Golden Omega Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Golden Omega Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Golden Omega Recent Developments
12.5 TASA
12.5.1 TASA Corporation Information
12.5.2 TASA Overview
12.5.3 TASA Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 TASA Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 TASA Recent Developments
12.6 Omega Protein
12.6.1 Omega Protein Corporation Information
12.6.2 Omega Protein Overview
12.6.3 Omega Protein Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Omega Protein Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Omega Protein Recent Developments
12.7 Croda
12.7.1 Croda Corporation Information
12.7.2 Croda Overview
12.7.3 Croda Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Croda Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Croda Recent Developments
12.8 GC Rieber
12.8.1 GC Rieber Corporation Information
12.8.2 GC Rieber Overview
12.8.3 GC Rieber Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 GC Rieber Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 GC Rieber Recent Developments
12.9 Polaris
12.9.1 Polaris Corporation Information
12.9.2 Polaris Overview
12.9.3 Polaris Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Polaris Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Polaris Recent Developments
12.10 Yuwang
12.10.1 Yuwang Corporation Information
12.10.2 Yuwang Overview
12.10.3 Yuwang Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Yuwang Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Yuwang Recent Developments
12.11 Auqi
12.11.1 Auqi Corporation Information
12.11.2 Auqi Overview
12.11.3 Auqi Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Auqi Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Auqi Recent Developments
12.12 Kinomega
12.12.1 Kinomega Corporation Information
12.12.2 Kinomega Overview
12.12.3 Kinomega Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Kinomega Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Kinomega Recent Developments
12.13 Skuny
12.13.1 Skuny Corporation Information
12.13.2 Skuny Overview
12.13.3 Skuny Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Skuny Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Skuny Recent Developments
12.14 Xinzhou
12.14.1 Xinzhou Corporation Information
12.14.2 Xinzhou Overview
12.14.3 Xinzhou Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Xinzhou Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Xinzhou Recent Developments
12.15 Renpu Pharmaceuticals
12.15.1 Renpu Pharmaceuticals Corporation Information
12.15.2 Renpu Pharmaceuticals Overview
12.15.3 Renpu Pharmaceuticals Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 Renpu Pharmaceuticals Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 Renpu Pharmaceuticals Recent Developments
12.16 Sinomega
12.16.1 Sinomega Corporation Information
12.16.2 Sinomega Overview
12.16.3 Sinomega Marine Bio-Based Omega 3 Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 Sinomega Marine Bio-Based Omega 3 Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 Sinomega Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Marine Bio-Based Omega 3 Industry Chain Analysis
13.2 Marine Bio-Based Omega 3 Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Marine Bio-Based Omega 3 Production Mode & Process
13.4 Marine Bio-Based Omega 3 Sales and Marketing
13.4.1 Marine Bio-Based Omega 3 Sales Channels
13.4.2 Marine Bio-Based Omega 3 Distributors
13.5 Marine Bio-Based Omega 3 Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Marine Bio-Based Omega 3 Industry Trends
14.2 Marine Bio-Based Omega 3 Market Drivers
14.3 Marine Bio-Based Omega 3 Market Challenges
14.4 Marine Bio-Based Omega 3 Market Restraints
15 Key Finding in The Global Marine Bio-Based Omega 3 Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer